ING Groep NV boosted its position in shares of CME Group Inc. (NASDAQ:CME) by 185.7% during the second quarter, Holdings Channel reports. The firm owned 19,716 shares of the company’s stock after buying an additional 12,814 shares during the period. ING Groep NV’s holdings in CME Group were worth $1,920,000 as of its most recent SEC filing.
A number of other hedge funds have also recently modified their holdings of CME. Glenmede Trust Co. NA boosted its stake in shares of CME Group by 2.2% in the first quarter. Glenmede Trust Co. NA now owns 32,517 shares of the company’s stock worth $3,122,000 after buying an additional 710 shares during the period. Virginia Retirement System purchased a new stake in shares of CME Group during the first quarter worth approximately $500,000. CIBC World Markets Inc. purchased a new stake in shares of CME Group during the first quarter worth approximately $860,000. Ngam Advisors L.P. boosted its stake in shares of CME Group by 8.9% in the first quarter. Ngam Advisors L.P. now owns 37,903 shares of the company’s stock worth $3,641,000 after buying an additional 3,094 shares during the period. Finally, TIAA CREF Investment Management LLC boosted its stake in shares of CME Group by 21.8% in the first quarter. TIAA CREF Investment Management LLC now owns 989,117 shares of the company’s stock worth $95,005,000 after buying an additional 176,790 shares during the period. 80.29% of the stock is currently owned by institutional investors and hedge funds.
Shares of CME Group Inc. (NASDAQ:CME) traded up 0.13% during midday trading on Wednesday, hitting $104.06. 1,466,460 shares of the stock traded hands. The company’s 50-day moving average is $106.82 and its 200 day moving average is $99.32. CME Group Inc. has a 52 week low of $81.87 and a 52 week high of $110.35. The firm has a market capitalization of $35.26 billion, a PE ratio of 26.28 and a beta of 0.83.
CME Group (NASDAQ:CME) last posted its quarterly earnings data on Thursday, July 28th. The company reported $1.14 EPS for the quarter, topping the consensus estimate of $1.11 by $0.03. CME Group had a net margin of 38.22% and a return on equity of 6.83%. The business had revenue of $906 million for the quarter, compared to analyst estimates of $897.84 million. During the same quarter in the previous year, the firm posted $0.95 earnings per share. CME Group’s quarterly revenue was up 10.5% on a year-over-year basis. Analysts anticipate that CME Group Inc. will post $4.44 earnings per share for the current year.
The firm also recently disclosed a quarterly dividend, which was paid on Monday, September 26th. Investors of record on Friday, September 9th were paid a dividend of $0.60 per share. This represents a $2.40 annualized dividend and a yield of 2.31%. The ex-dividend date was Wednesday, September 7th. CME Group’s payout ratio is currently 60.61%.
A number of equities analysts have recently issued reports on the stock. Zacks Investment Research cut shares of CME Group from a “hold” rating to a “sell” rating in a research report on Monday, June 20th. Credit Agricole SA cut their price objective on shares of CME Group from $100.00 to $95.00 and set an “underperform” rating on the stock in a research report on Thursday, July 14th. Barclays PLC cut their price objective on shares of CME Group from $100.00 to $99.00 and set an “equal weight” rating on the stock in a research report on Friday, July 29th. Deutsche Bank AG increased their price objective on shares of CME Group from $110.00 to $111.00 and gave the stock a “buy” rating in a research report on Friday, July 29th. Finally, Keefe, Bruyette & Woods increased their price objective on shares of CME Group from $99.00 to $103.00 and gave the stock a “market perform” rating in a research report on Friday, July 29th. Two research analysts have rated the stock with a sell rating, six have assigned a hold rating and six have given a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus target price of $103.18.
In other news, Director James E. Oliff sold 1,000 shares of the company’s stock in a transaction that occurred on Friday, July 15th. The shares were sold at an average price of $102.30, for a total value of $102,300.00. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO Phupinder Gill sold 30,002 shares of the company’s stock in a transaction that occurred on Monday, September 19th. The stock was sold at an average price of $110.00, for a total transaction of $3,300,220.00. Following the completion of the transaction, the chief executive officer now owns 116,222 shares in the company, valued at approximately $12,784,420. The disclosure for this sale can be found here. Corporate insiders own 0.61% of the company’s stock.
CME Group Company Profile
CME Group Inc is a provider of products across all major asset classes, based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals. The Company’s products include both exchange-traded and privately negotiated futures and options contracts and swaps. The Company connects buyers and sellers together through its CME Globex electronic trading platform across the globe and its open outcry trading facilities in Chicago and New York City.
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME).
Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.